News Releases

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) is pleased to announce results of voting at its annual general meeting (“AGM”) of unitholders held on May 11, 2022. All of…

– Continued strong performance of existing assets and financial results – – Completion of Vonjo™ royalty transaction – TORONTO, May 10, 2022 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX:…

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that the Trust will participate in the following investor conferences in the month of May: Bloom Burton & Co….

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its first quarter 2022 financial results on Wednesday, May 11, 2022, at

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that a subsidiary of the Trust has entered into an amended and restated credit agreement (the “Amended…

– Announced growth-oriented and accretive transactions of up to $186 million – – Continued strong performance of existing assets and financial results – – Acquired over one million units under…

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI”) today announced that it has been notified by CTI BioPharma Corp. (“CTI”) that the U.S. Food and Drug Administration (“FDA”) has approved…

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its fourth quarter and full-year 2021 financial results on Tuesday,…

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that its Board of Trustees has declared a special cash distribution in the amount of US$0.22 per trust unit….

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that it has been notified by CTI BioPharma Corp. (CTI) that the U.S. Food and Drug Administration (FDA) has…